Home/ Supplements/ Alpha Lipoic Acid/ Stabilized R-Lipoic Acid Supreme

Stabilized R-Lipoic Acid Supreme

product on market Capsule Designs for Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

R-lipoic acid and biotin are supported by moderate evidence for supporting metabolic function and cellular energy production. Taurine is researched for its role in osmotic regulation and antioxidant defense. Overall, these ingredients have a strong safety profile for general supplementation.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Stabilized R-Lipoic Acid Supreme
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

4 mg (1333% DV)
133.3× RDA — above typical dose 27 studies (A:0, B:11)
500 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
100 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Potassium Bicarbonate Microcrystalline Cellulose Silicon Dioxide Vegetable Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take one capsule per day with a meal, or as directed by your health care practitioner.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Formulation Notes

Does not contain gluten.

Additional Information

Notice: Color, size or shape may appear different between lots.

RLA060-1

For Professional Use Only

Our Stabilized R-Lipoic Acid is in the form of Potassium-R-Lipoate, the preferred and only commercially available stable form of R-Lipoic acid. Binding it to potassium prevents it from polymerizing, which occurs easily due to its hygroscopic nature. This stable, non-hygroscopic, non-polymeric potassium salt form of R-Lipoic Acid does not require any special handling or refrigeration. The capsules are free of residual solvents and moisture.

Guaranteed GMP COMPLIANT Products

Notice: Color, size or shape may appear different between lots.

STORE IN A COOL, DRY PLACE.

Manufactured in an NSF GMP Registered Facility

Metadata

Product Details

UPC / SKU8 79452 00199 2
DSLD Entry Date2013-06-25
Product TypeOther Combinations
FormCapsule
DSLD ID23192
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.